Tom Beer, M.D., F.A.C.P., left, deputy director, OHSU Knight Cancer Institute Director, is principal investigator on the PATHFINDER study, which will evaluate the use of an early detection test to identify many types of cancer in a single blood draw. (OHSU/Kristyna Wentz-Graff)
